Inactive Instrument

CuraGen Corporation Share Price

Stocks

End-of-day quote Nasdaq Other stock markets
- ^USD	-

31/09/31	CURAGEN CO USD0.01 : CuraGen Reports Second Quarter 2009 Financial Results	PR
30/-1/30	CURAGEN : Reports Third Quarter 2008 Financial Results	PR
30/-1/30	CURAGEN : to Host Conference Call and Webcast to Discuss Third Quarter 2008 Financial Results and CR011-vcMMAE Phase II Trial Results on November 3, 2008	PR
30/-1/30	CURAGEN : Corporation Receives Notification from NASDAQ	PR
30/-1/30	CURAGEN : Reports Second Quarter 2008 Financial Results and Clinical Progress of CR011-vcMMAE	PR

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
REGENERON PHARMACEUTICALS, INC.	+4.73%	+3.38%	+19.53%	-8.89%	6.66TCr
UCB	-1.93%	+0.39%	+58.62%	+226.33%	5.65TCr
SAMSUNG BIOLOGICS CO.,LTD.	+1.07%	+42.10%	+42.10%	+42.10%	4.3TCr
CSL LIMITED	+3.45%	+6.04%	-49.46%	-55.91%	4.05TCr
BIOGEN INC.	+3.04%	+0.04%	+62.66%	-24.29%	3.19TCr
MODERNA, INC.	+10.01%	+18.57%	+161.59%	-34.48%	3.16TCr
INCYTE CORPORATION	+2.68%	+2.73%	+70.72%	+88.24%	2.33TCr
INNOVENT BIOLOGICS, INC.	+2.87%	+16.83%	+3.78%	+192.67%	1.95TCr
SWEDISH ORPHAN BIOVITRUM AB	-0.13%	+2.75%	+67.48%	+130.07%	1.72TCr
Average	+2.87%	+8.76%	+48.56%	+61.76%	3.67TCr
Weighted average by Cap.	+2.79%	+7.31%	+43.69%	+54.30%

Employees

Sector